Paper42226151
CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy.
Huang M and 5 others. BMC Vet Res, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy. Papers, record 42226151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226151
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CRISPR-Cas9-mediated construction of a Streptococcus agalactiae vaccine for tilapia and evaluation of its protective efficacy.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Streptococcus agalactiae | Major topic |
| Fish Diseases | Major topic |
| Streptococcal Infections | Major topic |
| Tilapia | Major topic |
| CRISPR-Cas Systems | Major topic |
| Streptococcal Vaccines | Major topic |
| Animals |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AB22013007 | the Fangchenggang Science and Technology Program | PubMed | ||
| AA17204081-1 | Guangxi Science and Technology Program | PubMed |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32,717,322 | Efficacy of two adjuvants administrated with a novel hydrogen peroxide-inactivated vaccine against Streptococcus agalactiae in Nile tilapia fingerlings. | Fish Shellfish Immunol | 2020 | https://conductscience.org/library/papers/32717322 | PubMed |
| 2 | 40,689,231 | Development of a CRISPR/Cas9 genome editing toolbox for Corynebacterium stationis and its application in hypoxanthine biosynthesis. | Synth Syst Biotechnol | 2025 | https://conductscience.org/library/papers/40689231 | PubMed |
| 3 | 36,822,292 | Characterization and evaluation of an oral vaccine via nano-carrier for surface immunogenic protein (Sip) delivery against Streptococcus agalactiae infection. | Int J Biol Macromol | 2023 | https://conductscience.org/library/papers/36822292 | PubMed |
| 4 | 21,414,351 | Advances in fish vaccine delivery. | Dev Comp Immunol | 2011 | https://conductscience.org/library/papers/21414351 | PubMed |
| 5 | 38,493,985 | Biology and functions of fish thrombocytes: A review. | Fish Shellfish Immunol | 2024 | https://conductscience.org/library/papers/38493985 | PubMed |
| 6 | 17,394,525 | Evaluation of the link between gyrodactylosis and streptococcosis of Nile tilapia, Oreochromis niloticus (L.). | J Fish Dis | 2007 | https://conductscience.org/library/papers/17394525 | PubMed |
| 7 | 38,184,180 | Immune response and protective efficacy of Streptococcus agalactiae vaccine coated with chitosan oligosaccharide for different immunization strategy in nile tilapia (Oreochromis niloticus). | Fish Shellfish Immunol | 2024 | https://conductscience.org/library/papers/38184180 | PubMed |
| 8 | 26,139,332 | Microbiota metabolite regulation of host immune homeostasis: a mechanistic missing link. | Curr Allergy Asthma Rep | 2015 | https://conductscience.org/library/papers/26139332 | PubMed |
| 9 | 22,745,249 | A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. | Science | 2012 | https://conductscience.org/library/papers/22745249 | PubMed |
| 10 | 31,374,315 | Development of an attenuated oral vaccine strain of tilapia Group B Streptococci serotype Ia by gene knockout technology. | Fish Shellfish Immunol | 2019 | https://conductscience.org/library/papers/31374315 | PubMed |
| 11 | 24,011,059 | Transformation of chemically competent E. coli. | Methods Enzymol | 2013 | https://conductscience.org/library/papers/24011059 | PubMed |
| 12 | 34,816,409 | Testing Novel Inactivation Methods and Adjuvants for Vaccines Against Streptococcus agalactiae in Nile Tilapia Oreochromis niloticus. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34816409 | PubMed |
| 13 | 32,970,777 | Determination of a novel parvovirus pathogen associated with massive mortality in adult tilapia. | PLoS Pathog | 2020 | https://conductscience.org/library/papers/32970777 | PubMed |
| 14 | 37,798,358 | An expanded CRISPR-Cas9-assisted recombineering toolkit for engineering genetically intractable Pseudomonas aeruginosa isolates. | Nat Protoc | 2023 | https://conductscience.org/library/papers/37798358 | PubMed |
| 15 | 39,833,194 | Engineered CRISPR-Cas9 for Streptomyces sp. genome editing to improve specialized metabolite production. | Nat Commun | 2025 | https://conductscience.org/library/papers/39833194 | PubMed |
| 16 | 31,953,479 | Novel Chimeric Multiepitope Vaccine for Streptococcosis Disease in Nile Tilapia (Oreochromis niloticus Linn.). | Sci Rep | 2020 | https://conductscience.org/library/papers/31953479 | PubMed |
| 17 | 39,561,912 | Survival, serum biochemical parameters, hepatic antioxidant status, and gene expression of three Nile tilapia strains under pathogenic Streptococcus agalactiae challenge. | Fish Shellfish Immunol | 2024 | https://conductscience.org/library/papers/39561912 | PubMed |
| 18 | 36,717,067 | Comparative study of the effects of Montanide™ ISA 763A VG and ISA 763B VG adjuvants on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus). | Fish Shellfish Immunol | 2023 | https://conductscience.org/library/papers/36717067 | PubMed |
| 19 | 41,072,832 | IL-11 acts as a vaccine adjuvant in Nile tilapia (Oreochromis niloticus) against Streptococcus agalactiae, enhancing both cellular and humoral immune responses. | Fish Shellfish Immunol | 2026 | https://conductscience.org/library/papers/41072832 | PubMed |
| 20 | 31,751,658 | An effective live attenuated vaccine against Streptococcus agalactiae infection in farmed Nile tilapia (Oreochromis niloticus). | Fish Shellfish Immunol | 2020 | https://conductscience.org/library/papers/31751658 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226151
GET https://conductscience.org/api/papers/v1/42226151/references?page=2